3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
24
Thoracic
2
Head & Neck
2
Gynecologic
2
CNS
2
Sarcoma
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Stomach Neoplasms
19
Carcinoma, Hepatocellular
18
Pancreatic Neoplasms
14
Colorectal Neoplasms
12
Esophageal Neoplasms
9
Neoplasm Metastasis
8
Esophageal Squamous Cell Carcinoma
7
Biliary Tract Neoplasms
7
Lung Neoplasms
6
Liver Neoplasms
6
Cholangiocarcinoma
6
Breast Neoplasms
6
Neoplasms
5
Colonic Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Melanoma
3
Sarcoma
2
Rectal Neoplasms
2
Advanced Pancreatic Cancer
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Tuberous Sclerosis
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Resectable Esophageal Squamous Cell Carcinoma
1
Recurrence
1
Prostatic Neoplasms
1
Pancreatic Cancer Metastatic
1
Ovarian Neoplasms
1
Oligometastatic Gastrointestinal Cancer
1
Interventions
pembrolizumab
17
Surveys and Questionnaires
12
Specimen Handling
11
Docetaxel
11
Nivolumab
9
Interviews as Topic
9
Standard of Care
8
Gemcitabine
8
Early Intervention, Educational
8
olaparib
7
enzalutamide
7
Magnetic Resonance Spectroscopy
7
Psychiatric Rehabilitation
6
Paclitaxel
6
durvalumab
5
Trastuzumab
5
Radiotherapy
5
Ipilimumab
5
Carboplatin
5
Bevacizumab
5
pertuzumab
4
palbociclib
4
cabozantinib
4
atezolizumab
4
abiraterone
4
Therapeutics
4
Taxes
4
Oxaliplatin
4
Methods
4
Immunoglobulin G
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
Injections
×
Gastrointestinal
×
Clear all
NCT02584400
2019-03-08
HX4 SD
Maastricht Radiation Oncology
Phase 2
Terminated
1 enrolled